Fundraising FoxInversago
acquired by Novo Nordisk10 known investors
Find your way into Inversago
Sign up to find every way you can get introduced to Inversago
- Your email: who you already know at Inversago, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Inversago team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Portfolio company acquired by Novo Nordisk for $1.1B USD.
Investors · 10
How we know: a partner's Signal profile · funding news · theglobeandmail.com · Not right? Tell us
How we know: Genesys Capital's portfolio page · funding news · theglobeandmail.com · Not right? Tell us
How we know: funding news · press coverage · Not right? Tell us
How we know: a partner's Signal profile · theglobeandmail.com · Not right? Tell us
How we know: Tarnagulla Ventures's portfolio page · Not right? Tell us
How we know: funding news · press coverage · Not right? Tell us
How we know: theglobeandmail.com · Not right? Tell us
How we know: a partner's Signal profile · funding news · theglobeandmail.com · Not right? Tell us
Also in the syndicate · 1
Frequently asked questions
- What does Inversago do?
- Portfolio company acquired by Novo Nordisk for $1.1B USD.
- Who are Inversago's investors?
- Inversago's investors include AmorChem, Genesys Capital, JDRF T1D Fund, New Enterprise Associates (NEA), Tarnagulla Ventures, adMare BioInnovations, Amgen Ventures, Fonds de solidarité FTQ and 1 more.
- Who acquired Inversago?
- Inversago was acquired by Novo Nordisk.